Skip to content
  • There are no suggestions because the search field is empty.
nav-feature_csa-monitor

Check Out Our Latest Product Release

CSA Monitor tracks your driver and risk data in real time.

Learn More
nav-feature_dash

Reach Your Business Goals with Dash

Foley's customizable platform for your unique initiatives.

Learn More
nav-feature_resources

New Resources Waiting for You & Your Team

Expert, always-free resources at your fingertips.

Learn More
DOT Issues Statement on Use of CBD Products
Admin
2 mins read
The Federal Motor Carrier Safety Administration issued a DOT Clearinghouse update last week to remind motor carriers and safety-sensitive drivers to use caution when using hemp and cannabidiol (CBD) products.

The FMCSA has issued these reminders in the past – the last time was prompted by the Farm Bill of 2018, which removed hemp from the definition of marijuana under the Controlled Substances Act.  It also stated that as long as a hemp-derived product (such as CBD) has less than 0.3 percent tetrahydrocannabinol (THC), it is not a controlled substance.

Related Article: The Rising Use of Marijuana

The confusion, is whether safety-sensitive employees such as truck drivers, bus drivers, transit vehicle operators or pilots can safely use CBD products while enrolled in a federal drug and alcohol testing program. The answer, is that while CBD products that fall under the THC threshold aren’t technically a controlled substance, it’s in the employee’s best interest to avoid them entirely as many contain higher levels of THC than the label indicates.

Make Life Easier With Digital & Fully Compliant DOT Drug Testing Programs- Learn More

“The Food and Drug Administration (FDA) does not currently certify the levels of THC in CBD products, so there is no Federal oversight to ensure that the labels are accurate,” the DOT noted. “The FDA has cautioned the public that: ‘Consumers should beware purchasing and using any [CBD] products.’”

Upgrade to an EASY DOT Drug Testing Program -  Contact Us Today!

The DOT went on to note that the FDA has already issued several warning letters to companies because the amount of CBD in their products was higher than indicated on the product label. If a safety-sensitive employee happened to use one of these products, for example, and then was called for a random drug test, they could end up with a positive drug test result. Because CBD is not a “legitimate medical explanation” for a confirmed positive marijuana result, it would result in the employee being pulled from safety-sensitive functions until the return-to-duty has been complete.

 
×
Fill out this form and a member of our team will reach out shorty.

Schedule a demo to see Dash in action.
A Foley expert is ready to help your company create a streamlined hiring, screening, and onboarding process that's easier for your candidate and team, while keeping you compliant with DOT and FMCSA requirements. Fill out this form, and we'll schedule a time for a personalized online demo of Dash.

FORM IMAGE (1)
Whether you’re looking for a quick background check, or a comprehensive DOT compliance solution, Foley can help.